{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:07:47Z","timestamp":1793156867841,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001724"],"award-info":[{"award-number":["82001724"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10067-022-06110-5","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:06:37Z","timestamp":1646071597000},"page":"2121-2128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-3998","authenticated-orcid":false,"given":"Dongmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-2263","authenticated-orcid":false,"given":"Binbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-8963","authenticated-orcid":false,"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7205-281X","authenticated-orcid":false,"given":"Zhuojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7274-1268","authenticated-orcid":false,"given":"Xiaojuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5125-6178","authenticated-orcid":false,"given":"Zongfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-3775","authenticated-orcid":false,"given":"Huiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-0105","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-7788","authenticated-orcid":false,"given":"Lindi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"issue":"7","key":"6110_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143(7):499\u2013516. https:\/\/doi.org\/10.7326\/0003-4819-143-7-200510040-00009","journal-title":"Ann Intern Med"},{"issue":"1","key":"6110_CR2","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","volume":"11","author":"KM Hoque","year":"2020","unstructured":"Hoque KM, Dixon EE, Lewis RM, Allan J, Gamble GD, Phipps-Green AJ, HalperinKuhns VL, Horne AM, Stamp LK, Merriman TR, Dalbeth N, Woodward OM (2020) The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat Commun 11(1):2767. https:\/\/doi.org\/10.1038\/s41467-020-16525-w","journal-title":"Nat Commun"},{"issue":"10156","key":"6110_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W (2018) Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet 392(10156):1403\u20131412. https:\/\/doi.org\/10.1016\/S0140-6736(18)32158-5","journal-title":"Lancet"},{"issue":"9654","key":"6110_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, K\u00f6ttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372(9654):1953\u20131961. https:\/\/doi.org\/10.1016\/S0140-6736(08)61343-4","journal-title":"Lancet"},{"key":"6110_CR5","doi-asserted-by":"publisher","unstructured":"Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, Yamanashi Y, Kasuga H, Nakashima H, Nakamura T, Takada Y, Kawamura Y, Inoue H, Okada C, Utsumi Y, Ikebuchi Y, Ito K, Nakamura M, Shinohara Y, Hosoyamada M, Sakurai Y, Shinomiya N, Hosoya T, Suzuki H (2012) Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 3(764). https:\/\/doi.org\/10.1038\/ncomms1756","DOI":"10.1038\/ncomms1756"},{"issue":"3","key":"6110_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3760\/cma.j.issn.0578-1426.2017.03.021","volume":"56","author":"Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases","year":"2017","unstructured":"Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases (2017) Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases. Zhonghua Nei Ke Za Zhi 56(3):235\u2013248. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2017.03.021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"6110_CR7","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s10157-018-1586-y","volume":"22","author":"H Yu","year":"2018","unstructured":"Yu H, Liu X, Song Y, Cheng J, Bao H, Qin L, Zhou X, Wang L, Peng A (2018) Safety and efficacy of benzbromarone and febuxostat in hyperuricemia patients with chronic kidney disease: a prospective pilot study. Clin Exp Nephrol 22(6):1324\u20131330. https:\/\/doi.org\/10.1007\/s10157-018-1586-y","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"6110_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/imj.13173","volume":"46","author":"LK Stamp","year":"2016","unstructured":"Stamp LK, Haslett J, Frampton C, White D, Gardner D, Stebbings S, Taylor G, Grainger R, Kumar R, Kumar S, Kain T, Porter D, Corkill M, Cathro A, Metcalfe S, Wyeth J, Dalbeth N (2016) The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. Intern Med J 46(9):1075\u20131080. https:\/\/doi.org\/10.1111\/imj.13173","journal-title":"Intern Med J"},{"issue":"1","key":"6110_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","volume":"59","author":"VF Azevedo","year":"2019","unstructured":"Azevedo VF, Kos IA, Vargas-Santos AB, da Rocha Castelar Pinheiro G, Dos Santos Paiva E (2019) Benzbromarone in the treatment of gout. Adv Rheumatol 59(1):37. https:\/\/doi.org\/10.1186\/s42358-019-0080-x","journal-title":"Adv Rheumatol"},{"issue":"2","key":"6110_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5414\/CP202629","volume":"55","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Su J, Zhou T, Tian J, Chen X, Zhu J (2017) A study comparing the safety and efficacy of febuxostat, allopurinol, and benzbromarone in Chinese gout patients: a retrospective cohort study. Int J Clin Pharmacol Ther 55(2):163\u2013168. https:\/\/doi.org\/10.5414\/CP202629","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4 Suppl 2","key":"6110_CR11","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/RHU.0b013e31821d36f2","volume":"17","author":"T Hosoya","year":"2011","unstructured":"Hosoya T, Ohno I (2011) A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study. J Clin Rheumatol 17(4 Suppl 2):S27-34. https:\/\/doi.org\/10.1097\/RHU.0b013e31821d36f2","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"6110_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13075-019-1976-x","volume":"21","author":"N Liang","year":"2019","unstructured":"Liang N, Sun M, Sun R, Xu T, Cui L, Wang C, Ma L, Cheng X, Xue X, Sun W, Yuan X, Zhang H, Li H, He Y, Ji A, Wu X, Li C (2019) Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort. Arthritis Res Ther 21(1):200. https:\/\/doi.org\/10.1186\/s13075-019-1976-x","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"6110_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"6887","key":"6110_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417(6887):447\u2013452. https:\/\/doi.org\/10.1038\/nature742","journal-title":"Nature"},{"issue":"3","key":"6110_CR15","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1074\/jbc.M208307200","volume":"278","author":"K Okamoto","year":"2003","unstructured":"Okamoto K, Eger BT, Nishino T, Kondo S, Pai EF, Nishino T (2003) An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J Biol Chem 278(3):1848\u20131855. https:\/\/doi.org\/10.1074\/jbc.M208307200","journal-title":"J Biol Chem"},{"issue":"7","key":"6110_CR16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3899\/jrheum.101156","volume":"38","author":"DS Goldfarb","year":"2011","unstructured":"Goldfarb DS, MacDonald PA, Hunt B, Gunawardhana L (2011) Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. J Rheumatol 38(7):1385\u20131389. https:\/\/doi.org\/10.3899\/jrheum.101156","journal-title":"J Rheumatol"},{"key":"6110_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14814","author":"A Chewcharat","year":"2020","unstructured":"Chewcharat A, Chen Y, Thongprayoon C, Harrison AM, Mao MA, Cheungpasitporn W (2020) Febuxostat as a renoprotective agent for treatment of hyperuricemia: a meta-analysis of randomized controlled trials. Intern Med J. https:\/\/doi.org\/10.1111\/imj.14814","journal-title":"Intern Med J"},{"issue":"29","key":"6110_CR18","doi-asserted-by":"publisher","first-page":"e16311","DOI":"10.1097\/MD.0000000000016311","volume":"98","author":"TC Lin","year":"2019","unstructured":"Lin TC, Hung LY, Chen YC, Lo WC, Lin CH, Tam KW, Wu MY (2019) Effects of febuxostat on renal function in patients with chronic kidney disease: a systematic review and meta-analysis. Medicine (Baltimore) 98(29):e16311. https:\/\/doi.org\/10.1097\/MD.0000000000016311","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06110-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T11:13:25Z","timestamp":1654859605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06110-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6110"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06110-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Ethics Committee of Zhongshan Hospital in Shanghai and the approval number is B2021-230. This study also complied with the ethical principles of the 1975 Declaration of Helsinki. Due to the retrospective nature of the study, patient informed consent was exempted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}